ALDH1A3 expression in the breast tumor cells results in decreased GABA and its intermediates N-acetylputrescine and glutamate, suggesting a potential increased utilization of GABA and/or its intermediates by cells expressing high levels of ALDH1A3. This evidence concerns the gene ALDH1A3 and breast neoplasm.